Overcoming Challenges with a Patient-Centered Approach in the Management of Overactive Bladder

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2018 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from February 1, 2019 to February 1, 2020

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Astellas

Description:
Affecting approximately 33 million people, overactive bladder (OAB) is a highly prevalent condition. It has a significant impact on quality of life (QoL), co-morbidities and cost; sufferers are two to three times more likely to experience disturbed sleep, overeating, poor self-esteem, and depression. Once diagnosed, there are a variety of treatments available. There is a stepwise progression in the management of OAB and multiple options of treatment available in each of the lines of therapy provide for a tailored approach to individualize treatment based upon a patient’s expectation and goal for treatment, their co-morbidities, symptoms, and the side-effects of treatments. What works and does not work will vary patient to patient, and it’s important to keep communications open to determine if a patient is unable to remain compliant to treatment due to side-effects or cost.

Upon completion of this activity, participants will be able to:

  • Discuss the differential diagnosis of overactive bladder (OAB) and underlying medical conditions that may impact bladder function

  • Compare and contrast the costs, safety, efficacy and mechanisms of action in anti-muscarinic agents and ß3-adrenoceptor agonists in OAB management

  • Discuss strategies to engage in more effective patient, provider and payer dialogues to identify the patient’s needs and improve outcomes for OAB

  • Apply methods to enable optimal cost management of current therapies to be realized by multiple OAB stakeholders including managed care organizations

  • Provide proper counseling and support to patients with OAB to increase their motivation for treatment-plan adherence and to improve patient quality of life
     

Faculty: David Staskin, MD
Associate Professor of Urology
Tufts University School of Medicine
St. Elizabeth’s Medical Center – Steward Health

Disclosure:

Dr. Staskin serves on an advisory board for Astellas, Ferring, and Velicept. He serves as a consultant for Astellas, Ferring, Roivant and Velicept. He has received research/grant support from Astellas, Urovant, and Velicept. He serves on the speaker's bureau for Astellas. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Astellas

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue